Limited Competition for Renewal Applications: Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)

As part of the FDA's Advancing Regulatory Science Initiative, the Office of Chief Scientist supports innovation to improve the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA regulated products. The purpose of this funding opportunity is to provide support for two Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) at the University of Maryland, and Georgetown University. The CERSIs will continue to foster an innovative and thematically coherent approach to advance the field of regulatory science (including laboratory, population, behavioral, and manufacturing sciences) and FDA's Advancing Regulatory Science Initiative toward more effective and efficient product development and evaluation.